Literature DB >> 3602353

Radiation carcinogenesis: time-dose relationships.

R L Ullrich, M C Jernigan, L C Satterfield, N D Bowles.   

Abstract

The present studies were undertaken to examine the time-dose relationships for the induction of lung adenocarcinomas and mammary adenocarcinomas in female BALB/c mice following gamma irradiation. Twelve-week-old female BALB/c/An NBd mice were irradiated with 137Cs gamma rays, and lifetime tumor incidences following high-dose-rate, low-dose-rate, or fractionated exposure regimens were compared. Analysis of the results indicated that the data could be fitted by linear-quadratic dose-response models for the induction of both tumors following acute doses and a linear model with a slope similar to that for the linear portion of the linear quadratic following low-dose-rate exposure regimens. When doses were fractionated the response was dependent upon the dose per fraction. If the dose per fraction was a dose which was predominantly on the linear portion of the acute dose response curve, then the response was linear and similar to that after low-dose-rate exposures. If the dose per fraction was in a region where the quadratic portion of the acute dose-response was significant, then the tumor incidence was higher than that following low-dose-rate exposures.

Entities:  

Mesh:

Year:  1987        PMID: 3602353

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  11 in total

Review 1.  Defining molecular and cellular responses after low and high linear energy transfer radiations to develop biomarkers of carcinogenic risk or therapeutic outcome.

Authors:  Michael Story; Liang-hao Ding; William A Brock; K Kian Ang; Ghazi Alsbeih; John Minna; Seongmi Park; Amit Das
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

2.  Cancer risks after medical radiation.

Authors:  P F Hall
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

Review 3.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

Review 4.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.

Authors:  X George Xu; Bryan Bednarz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-06-09       Impact factor: 3.609

5.  Probability Distribution of Dose and Dose-Rate Effectiveness Factor for use in Estimating Risks of Solid Cancers From Exposure to Low-Let Radiation.

Authors:  David C Kocher; A Iulian Apostoaei; F Owen Hoffman; John R Trabalka
Journal:  Health Phys       Date:  2018-06       Impact factor: 1.316

6.  Mutational Analysis of Ionizing Radiation Induced Neoplasms.

Authors:  Amy L Sherborne; Philip R Davidson; Katharine Yu; Alice O Nakamura; Mamunur Rashid; Jean L Nakamura
Journal:  Cell Rep       Date:  2015-09-03       Impact factor: 9.423

Review 7.  Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.

Authors:  Leena Rivina; Robert Schiestl
Journal:  Int J Environ Res Public Health       Date:  2012-12-27       Impact factor: 3.390

8.  High Energy Particle Radiation-associated Oncogenic Transformation in Normal Mice: Insight into the Connection between Activation of Oncotargets and Oncogene Addiction.

Authors:  Natarajan Aravindan; Sheeja Aravindan; Krishnan Manickam; Mohan Natarajan
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

9.  Genetic differences in transcript responses to low-dose ionizing radiation identify tissue functions associated with breast cancer susceptibility.

Authors:  Antoine M Snijders; Francesco Marchetti; Sandhya Bhatnagar; Nadire Duru; Ju Han; Zhi Hu; Jian-Hua Mao; Joe W Gray; Andrew J Wyrobek
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.

Authors:  Steve Braunstein; Jean L Nakamura
Journal:  Front Oncol       Date:  2013-04-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.